Exact Mass: 443.1553

Dihydrofolic acid

C19H21N7O6 (443.1553)

Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division. It can be targeted with drug analogs to prevent nucleic acid synthesis. Dihydrofolic acid is also known by the name Dihydrofolate - more commonly Vitamin B9. [HMDB] Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division. It can be targeted with drug analogs to prevent nucleic acid synthesis. Dihydrofolic acid is also known by the name Dihydrofolate - more commonly Vitamin B9. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid.

3-O-acetyl-4-O-demethylpapaveroxine

C23H25NO8 (443.158)

CID 9980845

C24H21N5O4 (443.1593)

Fumiquinazoline C

C24H21N5O4 (443.1593)

A fumiquinazoline obtained by oxidative spirocyclisation of fumiquinazoline A.

2-(4-(((2-Amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

C19H21N7O6 (443.1553)

Pevonedistat

C21H25N5O4S (443.1627)

fumiquinazoline D

C24H21N5O4 (443.1593)

4-O-Desmethyl-3-O-acetylpapaveroxine

C23H25NO8 (443.158)

2-O-(2S-Amino-3R-hydroxybutanoyl)sucrose

C16H29NO13 (443.1639)

MCULE-9549881617

C24H21N5O4 (443.1593)

(13S,14R)-13-O-acetyl-1,8-dihydroxy-N-methylcanadine

C23H25NO8 (443.158)

Oxytetracycline Impurity C

C23H25NO8 (443.158)

oxalatrunculin B

C20H29NO8S (443.1614)

beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-threonyl]glucopyranoside

C16H29NO13 (443.1639)

Tyr Met Met

C19H29N3O5S2 (443.1549)

Moricizine sulfoxide

C22H25N3O5S (443.1515)

Met Met Tyr

C19H29N3O5S2 (443.1549)

Met Tyr Met

C19H29N3O5S2 (443.1549)

NCGC00380154-01!

C24H21N5O4 (443.1593)

C24H21N5O4_2,17-Dimethyl-1,9a-dihydro-3H,16H-spiro[imidazo[1,2-a]indole-9,14-[13]oxa[2,10,17]triazatetracyclo[10.3.2.0~2,11~.0~4,9~]heptadeca[4,6,8,10]tetraene]-3,3,16(2H)-trione

C24H21N5O4 (443.1593)

C24H21N5O4_(1S,3S,12S,14R,27S)-12-Hydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1~2,5~.0~6,11~.0~12,27~.0~15,24~.0~17,22~]heptacosa-6,8,10,17,19,21,23-heptaene-4,16,26-trione (Fumiquinazoline C)

C24H21N5O4 (443.1593)

C24H21N5O4_(1S,3S,12S,14R,27S)-12-Hydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1~2,5~.0~6,11~.0~12,27~.0~15,24~.0~17,22~]heptacosa-6,8,10,17,19,21,23-heptaene-4,16,26-trione

C24H21N5O4 (443.1593)

[IIN-based on: CCMSLIB00000845724]

C24H21N5O4 (443.1593)

[IIN-based: Match]

C24H21N5O4 (443.1593)

Dihydrofolate

C19H21N7O6 (443.1553)

Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid.

Ala Cys His Asn

C16H25N7O6S (443.1587)

Ala Cys Asn His

C16H25N7O6S (443.1587)

Ala His Cys Asn

C16H25N7O6S (443.1587)

Ala His Asn Cys

C16H25N7O6S (443.1587)

Ala Asn Cys His

C16H25N7O6S (443.1587)

Ala Asn His Cys

C16H25N7O6S (443.1587)

Cys Ala His Asn

C16H25N7O6S (443.1587)

Cys Ala Asn His

C16H25N7O6S (443.1587)

Cys Gly His Gln

C16H25N7O6S (443.1587)

Cys Gly Gln His

C16H25N7O6S (443.1587)

Cys His Ala Asn

C16H25N7O6S (443.1587)

Cys His Gly Gln

C16H25N7O6S (443.1587)

Cys His Asn Ala

C16H25N7O6S (443.1587)

Cys His Gln Gly

C16H25N7O6S (443.1587)

Cys Asn Ala His

C16H25N7O6S (443.1587)

Cys Asn His Ala

C16H25N7O6S (443.1587)

Cys Gln Gly His

C16H25N7O6S (443.1587)

Cys Gln His Gly

C16H25N7O6S (443.1587)

Gly Cys His Gln

C16H25N7O6S (443.1587)

Gly Cys Gln His

C16H25N7O6S (443.1587)

Gly His Cys Gln

C16H25N7O6S (443.1587)

Gly His Gln Cys

C16H25N7O6S (443.1587)

Gly Gln Cys His

C16H25N7O6S (443.1587)

Gly Gln His Cys

C16H25N7O6S (443.1587)

His Ala Cys Asn

C16H25N7O6S (443.1587)

His Ala Asn Cys

C16H25N7O6S (443.1587)

His Cys Ala Asn

C16H25N7O6S (443.1587)

His Cys Gly Gln

C16H25N7O6S (443.1587)

His Cys Asn Ala

C16H25N7O6S (443.1587)

His Cys Gln Gly

C16H25N7O6S (443.1587)

His Gly Cys Gln

C16H25N7O6S (443.1587)

His Gly Gln Cys

C16H25N7O6S (443.1587)

His Asn Ala Cys

C16H25N7O6S (443.1587)

His Asn Cys Ala

C16H25N7O6S (443.1587)

His Gln Cys Gly

C16H25N7O6S (443.1587)

His Gln Gly Cys

C16H25N7O6S (443.1587)

Asn Ala Cys His

C16H25N7O6S (443.1587)

Asn Ala His Cys

C16H25N7O6S (443.1587)

Asn Cys Ala His

C16H25N7O6S (443.1587)

Asn Cys His Ala

C16H25N7O6S (443.1587)

Asn His Ala Cys

C16H25N7O6S (443.1587)

Asn His Cys Ala

C16H25N7O6S (443.1587)

Gln Cys Gly His

C16H25N7O6S (443.1587)

Gln Cys His Gly

C16H25N7O6S (443.1587)

Gln Gly Cys His

C16H25N7O6S (443.1587)

Gln Gly His Cys

C16H25N7O6S (443.1587)

Gln His Cys Gly

C16H25N7O6S (443.1587)

Gln His Gly Cys

C16H25N7O6S (443.1587)

2-[-N-(2-cyanoethyl)-4-[(p-nitrophenyl)azo]anilino]ethyl benzoate

C24H21N5O4 (443.1593)

1H-Pyrazole-4-carboxamide, N-[5-[(cyclopropylamino)carbonyl]-2-Methylphenyl]-5-Methyl-1-[3-(trifluoromethyl)-2-pyridinyl]-

C22H20F3N5O2 (443.1569)

Flumeridone

C22H23ClFN5O2 (443.1524)

C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent

2-[[4-[[4-[bis(2-hydroxyethyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]azo]-p-cresol

C20H22ClN7O3 (443.1473)

Disperse Orange 73

C24H21N5O4 (443.1593)

2-Acetyl-2-decarboxamidooxytetracycline

C23H25NO8 (443.158)

Pevonedistat

C21H25N5O4S (443.1627)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors

1,5-dimethyl-3-[(2-methyl-1H-indol-3-yl)azo]-2-phenyl-1H-pyrazolium methyl sulphate

C21H25N5O4S (443.1627)

rac-3-hydroxy-N,N-dimethylcoclaurinium trifluoroacetate

C21H24F3NO6 (443.1556)

A natural product found in Gnetum montanum.

(2S)-2-[(4-{[(2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}benzoyl)amino]pentanedioate

C19H21N7O6-2 (443.1553)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

2,17-Dimethylspiro[13-oxa-2,10,17-triazatetracyclo[10.3.2.02,11.04,9]heptadeca-4,6,8,10-tetraene-14,4-3,3a-dihydro-2H-imidazo[1,2-a]indole]-1,3,16-trione

C24H21N5O4 (443.1593)

Ethyl-[10-(3-morpholin-4-ylpropanoyl)-5-oxophenothiazin-2-yl]carbamic acid

C22H25N3O5S (443.1515)

(6S)-5,6,7,8-tetrahydrofolate(2-)

C19H21N7O6-2 (443.1553)

5-Hydroxy-a-6-deoxytetracycline

C22H23N2O8- (443.1454)

methyl 5-[1-amino-8,8-dimethyl-5-(morpholin-4-yl)-8,9-dihydro-6H-pyrano[4,3-d]thieno[2,3-b]pyridin-2-yl]furan-2-carboxylate

C22H25N3O5S (443.1515)

N-butan-2-yl-6-[(4-ethoxyphenyl)sulfamoyl]-4-oxo-1H-quinoline-3-carboxamide

C22H25N3O5S (443.1515)

N-(1,3-benzodioxol-5-ylmethyl)-3-methoxy-N-[(4-oxo-1H-quinazolin-2-yl)methyl]benzamide

C25H21N3O5 (443.1481)

2-Phenyl-N-(18-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12,14,16-octaen-16-yl)acetamide

C29H21N3O2 (443.1634)

(1S,4aS,11S,11aS,12aS)-3-carbamoyl-1-(dimethylazaniumyl)-4a,7,11-trihydroxy-11-methyl-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracene-2,5-diolate

C22H23N2O8- (443.1454)

(1S,9R,10R,11R)-12-[(3-chlorophenyl)methyl]-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C23H26ClN3O4 (443.1612)

(1R,9S,10S,11S)-12-[(3-chlorophenyl)methyl]-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C23H26ClN3O4 (443.1612)

Met-Met-Tyr

C19H29N3O5S2 (443.1549)

Tyr-Met-Met

C19H29N3O5S2 (443.1549)

Met-Tyr-Met

C19H29N3O5S2 (443.1549)

2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioate

C19H21N7O6-2 (443.1553)

(6R)-5,6,7,8-tetrahydrofolyl-(gamma-L-Glu)n

C19H21N7O6-2 (443.1553)

Dihydrofolic acid

C19H21N7O6 (443.1553)

A folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division and is targeted by various drugs to prevent nucleic acid synthesis. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid.

3-O-acetyl-4-O-demethylpapaveroxine

C23H25NO8 (443.158)

A benzylisoquinoline alkaloid that is 8-hydroxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline which is substituted at the 1-pro-R position by an (acetyloxy)(2-formyl-3,4-dimethoxyphenyl)methyl group. An intermediate in the biosynthesis of noscarpine in the opium poppy, Papaver somniferum.

(6S)-5,6,7,8-tetrahydrofolate(2-)

C19H21N7O6 (443.1553)

Dianion of (6S)-5,6,7,8-tetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.

2-(4-(((2-Amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

C19H21N7O6 (443.1553)

sulfamic acid [4-[4-(2,3-dihydro-1H-inden-1-ylamino)-7-pyrrolo[2,3-d]pyrimidinyl]-2-hydroxycyclopentyl]methyl ester

C21H25N5O4S (443.1627)

5,6,7,8-tetrahydrofolate(2-)

C19H21N7O6 (443.1553)

A dicarboxylic acid anion arising from deprotonation of both carboxylic acid functions of 5,6,7,8-tetrahydrofolic acid; major structure at pH 7.3

tetracycline(1-)

C22H23N2O8 (443.1454)

An organic anion that is the conjugate base of tetracycline obtained by deprotonation of the two enolic hydroxy groups and protonation of the tertiary amino group.

ST 18:3;O5;Tau

C20H29NO8S (443.1614)

MK-8617

C24H21N5O4 (443.1593)

MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2.

methyl 4-[(1-{10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene}ethyl)amino]butanoate

C23H25NO8 (443.158)

(1r,3s,12s,14r,27r)-12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

(11r,15r,17r)-4-hydroxy-5-[(2r,4r,5s,6r)-5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C23H25NO8 (443.158)

(1's,2s,9s,9as,12'r)-2,17'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10'-tetraene-3,3',16'-trione

C24H21N5O4 (443.1593)

(1'r,2s,9s,9as,12's)-16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)

12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

2,17'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10'-tetraene-3,3',16'-trione

C24H21N5O4 (443.1593)

(9's,9'ar)-9'-hydroxy-9'-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-1',9'a-dihydrospiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-3'-one

C24H21N5O4 (443.1593)

2-acetyl-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,11-dione

C23H25NO8 (443.158)

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s,3r)-2-amino-3-hydroxybutanoate

C16H29NO13 (443.1639)

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-amino-3-hydroxybutanoate

C16H29NO13 (443.1639)

(1s,3s,12s,14r,27s)-12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

(2r,3s,4s,5s,6s)-2-(1,2-dihydroxyethyl)-6-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-4-methoxyoxane-3,5-diol

C17H25N5O9 (443.1652)

16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)

(1r,3s,12s,14r,27s)-12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

methyl 4-({1-[(2r,4e)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene]ethyl}amino)butanoate

C23H25NO8 (443.158)

(1'r,2s,9s,9as,12'r)-16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)

(4s,4as,5as,6s,12as)-2-acetyl-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,11-dione

C23H25NO8 (443.158)

2-(1,2-dihydroxyethyl)-6-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-4-methoxyoxane-3,5-diol

C17H25N5O9 (443.1652)

9'-hydroxy-9'-({3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-1',9'a-dihydrospiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-3'-one

C24H21N5O4 (443.1593)

(1'r,2s,9s,9ar,12'r)-16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)